✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
Dihydroergotamine Mesylate is a drug marketed by Hikma, Hikma Pharms, Padagis Us, Provepharm Sas, Sagent Pharms Inc, Amneal, Cipla, and Custopharm Inc. and is included in eight NDAs.
The generic ingredient in DIHYDROERGOTAMINE MESYLATE is dihydroergotamine mesylate. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
A generic version of DIHYDROERGOTAMINE MESYLATE was approved as dihydroergotamine mesylate by PADAGIS US on April 28th, 2003.
Summary for DIHYDROERGOTAMINE MESYLATE
|Finished Product Suppliers / Packagers:||8|
|Raw Ingredient (Bulk) Api Vendors:||54|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for DIHYDROERGOTAMINE MESYLATE|
|What excipients (inactive ingredients) are in DIHYDROERGOTAMINE MESYLATE?||DIHYDROERGOTAMINE MESYLATE excipients list|
|DailyMed Link:||DIHYDROERGOTAMINE MESYLATE at DailyMed|
Recent Clinical Trials for DIHYDROERGOTAMINE MESYLATE
Identify potential brand extensions & 505(b)(2) entrants
|Ache Laboratorios Farmaceuticos S.A.||Phase 3|
|Xijing Hospital||Phase 2/Phase 3|
|Satsuma Pharmaceuticals, Inc.||Phase 3|
Pharmacology for DIHYDROERGOTAMINE MESYLATE
|Drug Class||Ergotamine Derivative |